Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, October 2, 2023
[ Mon, Oct 02nd 2023
] - WOPRAI
[ Mon, Oct 02nd 2023
] - WOPRAI
[ Mon, Oct 02nd 2023
] - WOPRAI
Fri, September 29, 2023
[ Fri, Sep 29th 2023
] - WOPRAI
[ Fri, Sep 29th 2023
] - WOPRAI
[ Fri, Sep 29th 2023
] - WOPRAI
[ Fri, Sep 29th 2023
] - WOPRAI
[ Fri, Sep 29th 2023
] - WOPRAI
[ Fri, Sep 29th 2023
] - WOPRAI
[ Fri, Sep 29th 2023
] - WOPRAI
[ Fri, Sep 29th 2023
] - WOPRAI
[ Fri, Sep 29th 2023
] - WOPRAI
[ Fri, Sep 29th 2023
] - WOPRAI
[ Fri, Sep 29th 2023
] - WOPRAI
[ Fri, Sep 29th 2023
] - WOPRAI
[ Fri, Sep 29th 2023
] - WOPRAI
[ Fri, Sep 29th 2023
] - WOPRAI
[ Fri, Sep 29th 2023
] - WOPRAI
[ Fri, Sep 29th 2023
] - WOPRAI
[ Fri, Sep 29th 2023
] - WOPRAI
[ Fri, Sep 29th 2023
] - WOPRAI
[ Fri, Sep 29th 2023
] - WOPRAI
[ Fri, Sep 29th 2023
] - WOPRAI
[ Fri, Sep 29th 2023
] - WOPRAI
[ Fri, Sep 29th 2023
] - WOPRAI
[ Fri, Sep 29th 2023
] - WOPRAI
[ Fri, Sep 29th 2023
] - WOPRAI
[ Fri, Sep 29th 2023
] - WOPRAI
[ Fri, Sep 29th 2023
] - WOPRAI
[ Fri, Sep 29th 2023
] - WOPRAI
Luke Sergott Maintained (TXG) at Buy with Decreased Target to $47 on, Sep 29th, 2023
Luke Sergott of Barclays, Maintained "10x Genomics, Inc." (TXG) at Buy with Decreased Target from $66 to $47 on, Sep 29th, 2023.
Luke has made no other calls on TXG in the last 4 months.
There are 4 other peers that have a rating on TXG. Out of the 4 peers that are also analyzing TXG, 0 agree with Luke's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Luke
- Kyle Mikson of "Canaccord Genuity" Reiterated at Strong Buy and Held Target at $70 on, Tuesday, September 19th, 2023
- Tejas Savant of "Morgan Stanley" Reiterated at Buy and Held Target at $65 on, Monday, August 7th, 2023
- Patrick Donnelly of "Citigroup" Maintained at Strong Buy with Increased Target to $75 on, Friday, August 4th, 2023
- Matthew Sykes of "Goldman Sachs" Maintained at Strong Sell with Increased Target to $30 on, Thursday, July 13th, 2023
